Financials and Filings

MGEN $3.51 $ - 0.13 (3.57%)

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
13-D SC 13G/A 11/13/2018
8-K 8-K 11/7/2018 11/7/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
10-Q 10-Q 11/7/2018 9/30/2018
8-K 8-K 10/1/2018 10/1/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Regulation FD Disclosure and Financial Statements and Exhibits.
10-Q 10-Q 8/8/2018 6/30/2018
8-K 8-K 8/7/2018 8/7/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 8/6/2018 8/6/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; and Financial Statements and Exhibits.
Registration Statement D 8/6/2018
8-K 8-K 7/10/2018 7/10/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 6/28/2018 6/27/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Submission of Matters to a Vote of Security Holder.
8-K 8-K 6/4/2018 6/4/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
Proxy DEF 14A 5/15/2018 6/27/2018
Proxy DEFA14A 5/15/2018
8-K 8-K 5/9/2018 5/9/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition; Other Events; and Financial Statements and Exhibits.
10-Q 10-Q 5/9/2018 3/31/2018
8-K 8-K 5/8/2018 5/8/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 5/2/2018 5/1/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 4/27/2018 4/27/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
10-K 10-K/A 4/20/2018 12/31/2017
8-K 8-K 4/6/2018 4/3/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Entry into a Material Definitive Agreement.

Displaying 1 to 20 (of 185 filings)